Cingulate Inc (CING) Price & Analysis

Q: What was Cingulate Inc’s price range in the past 12 months?

Cingulate Inc lowest stock price was $3.02 and its highest was $7.00 in the past 12 months.

Q: What is Cingulate Inc’s market cap?

Cingulate Inc’s market cap is $20.51M.

Q: When is Cingulate Inc’s upcoming earnings report date?

Cingulate Inc’s upcoming earnings report date is Nov 17, 2025 which is in 71 days.

Q: How were Cingulate Inc’s earnings last quarter?

Cingulate Inc released its earnings results on Aug 19, 2025. The company reported -$1.09 earnings per share for the quarter, missing the consensus estimate of -$0.915 by -$0.175.

Q: Is Cingulate Inc overvalued?

According to Wall Street analysts Cingulate Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Q: Does Cingulate Inc pay dividends?

Cingulate Inc does not currently pay dividends.

Q: What is Cingulate Inc’s EPS estimate?

Cingulate Inc’s EPS estimate is -0.88.

Q: How many shares outstanding does Cingulate Inc have?

Cingulate Inc has 5,412,523 shares outstanding.

Q: What happened to Cingulate Inc’s price movement after its last earnings report?

Cingulate Inc reported an EPS of -$1.09 in its last earnings report, missing expectations of -$0.915. Following the earnings report the stock price went down -9.615%.

Q: Which hedge fund is a major shareholder of Cingulate Inc?

Among the largest hedge funds holding Cingulate Inc’s share is GoalVest Advisory LLC. It holds Cingulate Inc’s shares valued at 0.

Compare

358 Followers

CING Stock Chart & Stats

Day’s Range― - ―

52-Week Range$3.02 - $7.00

Previous CloseN/A

Volume136.88K

Average Volume (3M)150.05K

Market Cap

$20.51M

Enterprise Value$15.55M

Total Cash (Recent Filing)$8.90M

Total Debt (Recent Filing)$6.58M

Price to Earnings (P/E)―

Beta5.16

Next Earnings

Nov 17, 2025

EPS Estimate

-0.88

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1.09

Shares Outstanding5,412,523

10 Day Avg. Volume134,081

30 Day Avg. Volume150,054

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.76

Enterprise Value/Revenue<0.01

Enterprise Value/Gross Profit<0.01

Enterprise Value/Ebitda-0.89

Forecast

1Y Price Target

$25.00

Price Target Upside541.03% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering4

Bulls Say, Bears Say

Bulls Say

Drug ApprovalThere is potential approval for CTx-1301 in the ADHD market, which could boost the company's prospects.

Market OpportunityConsidering the ongoing stimulant shortages, especially for generic stimulant products, and that CTx-1301 only requires one daily dose, the commercial opportunity for Cingulate is significant.

Technology InnovationCingulate's Precision Timed Release (PTR) drug delivery technology can deliver once-daily oral therapies that provide all-day efficacy while eliminating the need for boosters.

Bears Say

Financial ConcernsCingulate finished 1Q25 with $9.5M in cash and equivalents, which is sufficient to fund the company into 4Q25.

Regulatory RisksShares are trading down due to investor concerns around regulatory risks, including potential concerns about the Phase 3 data, commercial risks, or potential delays by the FDA.

Cingulate Inc News

Cingulate price target lowered to $10 from $11 at Roth Capital

Roth Capital analyst Boobalan Pachaiyappan lowered the firm’s price target on Cingulate (CING) to $10 from $11 but...

17d ago

CING

Cingulate reports Q2 net loss ($4.8M) vs ($3.2M) last year

As of June 30, 2025, Cingulate (CING) had approximately $8.9 million in cash and cash equivalents, a $3.3...

19d ago

CING

Cingulate places CEO Schaffer on administrative leave

The Board of Directors of Cingulate (CING) announced that it has placed Chairman and Chief Executive Officer, Shane...

23d ago

CING

Cingulate CEO tells Roth COO departure has no meaningful impact on CTx-1301

After Cingulate (CING) announced the termination of Laurie Myers as COO, Roth Capital caught up with Cingulate Therapeutics’...

30d ago

CING

Cingulate reports termination of Chief Operating Officer

In a regulatory filing, Cingulate (CING) disclosed that on August 7, the employment of Laurie Myers, Executive Vice...

30d ago

CING

Cingulate Inc Manages Debt with Stock Issuances

Cingulate Inc ( ($CING) ) just unveiled an announcement. Between July 22, 2025, and September 5, 2025, Cingulate...

1d ago

CING

Cingulate Inc Appoints New Executive Chairman Amid Changes

Cingulate Inc ( ($CING) ) has issued an announcement. On August 14, 2025, Cingulate Inc. appointed John A....

9d ago

CING

Cingulate Inc. Reports Q2 2025 Financial Results

Cingulate, Inc. ( ($CING) ) has released its Q2 earnings. Here is a breakdown of the information Cingulate,...

18d ago

CING

CING Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Cingulate, Inc. (CING) is scheduled to report 2nd quarter earnings on 08/19/2025. Regarding Q2 estimates, Wall Street analysts...

21d ago

CING

Cingulate Inc. Delays Quarterly Report Filing

Cingulate Inc ( ($CING) ) has released a notification of late filing. Cingulate Inc., a company based in...

23d ago

CING

Cingulate Inc CEO Shane Schaffer on Administrative Leave

An announcement from Cingulate Inc ( ($CING) ) is now available. On August 9, 2025, Shane Schaffer, CEO...

23d ago

CING

Cingulate Inc.’s Strategic Partnerships and NDA Submission Drive Buy Rating

Analyst Naz Rahman of Maxim Group reiterated a Buy rating on Cingulate Inc, retaining the price target of...

1M ago

CING

Cingulate Inc Submits NDA for ADHD Treatment

Cingulate Inc ( ($CING) ) has provided an announcement. Cingulate Inc. announced that on July 31, 2025, it...

1M ago

CING

Cingulate submits CTx-1301 NDA to FDA

Cingulate (CING) submitted its New Drug Application to the U.S. Food and Drug Administration for CTx-1301, the company’s...

1M ago

CING

CING FAQ

What was Cingulate Inc’s price range in the past 12 months?

Cingulate Inc lowest stock price was $3.02 and its highest was $7.00 in the past 12 months.

What is Cingulate Inc’s market cap?

Cingulate Inc’s market cap is $20.51M.

When is Cingulate Inc’s upcoming earnings report date?

Cingulate Inc’s upcoming earnings report date is Nov 17, 2025 which is in 71 days.

How were Cingulate Inc’s earnings last quarter?

Cingulate Inc released its earnings results on Aug 19, 2025. The company reported -$1.09 earnings per share for the quarter, missing the consensus estimate of -$0.915 by -$0.175.

Is Cingulate Inc overvalued?

According to Wall Street analysts Cingulate Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Cingulate Inc pay dividends?

Cingulate Inc does not currently pay dividends.

What is Cingulate Inc’s EPS estimate?

Cingulate Inc’s EPS estimate is -0.88.

How many shares outstanding does Cingulate Inc have?

Cingulate Inc has 5,412,523 shares outstanding.

What happened to Cingulate Inc’s price movement after its last earnings report?

Cingulate Inc reported an EPS of -$1.09 in its last earnings report, missing expectations of -$0.915. Following the earnings report the stock price went down -9.615%.

Which hedge fund is a major shareholder of Cingulate Inc?

Among the largest hedge funds holding Cingulate Inc’s share is GoalVest Advisory LLC. It holds Cingulate Inc’s shares valued at 0.

Company Description

Cingulate Inc

Cingulate Inc. is a biopharmaceutical company focused on the development, manufacturing, and commercialization of innovative therapies for the treatment of central nervous system disorders. Operating primarily in the healthcare and pharmaceutical sectors, the company is dedicated to addressing unmet medical needs through its portfolio of proprietary drug candidates, with a particular emphasis on attention deficit/hyperactivity disorder (ADHD) and anxiety disorders.

Cingulate Inc (CING) Earnings & Revenues

Historic Earnings Reports

CING Stock 12 Month Forecast

Average Price Target

$25.00

▲(541.03% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","63":"$63","17.25":"$17.25","32.5":"$32.5","47.75":"$47.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":62,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$62.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$25.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$8.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,17.25,32.5,47.75,63],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Jan<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.1,9.476923076923075,13.853846153846153,18.230769230769226,22.607692307692304,26.98461538461538,31.36153846153846,35.738461538461536,40.11538461538461,44.49230769230769,48.86923076923077,53.246153846153845,57.623076923076916,{"y":62,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.1,6.63076923076923,8.161538461538461,9.692307692307692,11.223076923076922,12.753846153846153,14.284615384615384,15.815384615384614,17.346153846153847,18.876923076923077,20.407692307692308,21.93846153846154,23.46923076923077,{"y":25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.1,5.323076923076923,5.546153846153846,5.769230769230769,5.992307692307692,6.2153846153846155,6.438461538461539,6.661538461538461,6.884615384615385,7.107692307692307,7.330769230769231,7.553846153846154,7.776923076923077,{"y":8,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.08,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.48,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.06,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.89,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.85,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.3,"date":1733011200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.93,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4.12,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.25,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.3,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.98,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.14,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.1,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >